Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: a systematic review

AH Simoni, J Frydenlund, KH Kragholm… - International journal of …, 2022 - Elsevier
Background Socioeconomic inequities in acute coronary syndrome (ACS) epidemiology and
care have been reported for at least 30–40 years. However, an up-to-date overview of …

The influence of patient expectations on adherence to treatment regimen after myocardial infarction

Ł Pietrzykowski, M Kasprzak, P Michalski… - Patient education and …, 2022 - Elsevier
Objective In-hospital patient education is one of the elements affecting patient adherence to
treatment regimen after myocardial infarction (MI). Its effectiveness is determined by …

Functioning of patients with post-COVID syndrome—preliminary data

A Kubica, P Michalski, M Kasprzak… - Medical Research …, 2021 - journals.viamedica.pl
Introduction: Post-COVID syndrome is a common finding during the first year after SARS-
CoV-2 infection affecting the daily living of many patients. The aim of this study was to …

Functioning in chronic disease—a key factor determining adherence to heart failure treatment

A Kubica, J Kubica - Medical Research Journal, 2022 - journals.viamedica.pl
Patients with heart failure require long-term medical treatment [1, 2]. Non-adherence to
medication is the main factor limiting treatment efficacy due to increased morbidity and …

[PDF][PDF] The therapeutic plan implementation in patients discharged from the hospital after myocardial infarction

A Kubica, Ł Pietrzykowski - Medical Research Journal, 2021 - journals.viamedica.pl
According to the European Society of Cardiology guidelines dual antiplatelet therapy
(DAPT) for 12 months, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin …

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients

J Kubica, A Kubica, K Grzelakowska… - Cardiology …, 2023 - journals.viamedica.pl
Several mechanisms have been suggested to explain positive cardiovascular effects
observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction …

[HTML][HTML] A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo …

J Kubica, P Adamski, P Niezgoda, A Kubica… - Cardiology …, 2021 - journals.viamedica.pl
The risk of ischemic events gradually decreases after acute coronary syndrome (ACS),
reaching a stable level after 1 month, while the risk of bleeding remains steady during the …

Implementation of therapeutic recommendations in high cardiovascular-risk patients. The Polish population of EUROASPIRE V survey

E Laskowska, P Michalski… - Medical Research …, 2021 - journals.viamedica.pl
Introduction: Poor medication adherence is associated with unsatisfactory health outcomes,
elevated mortality, and high costs of medical care. This study aimed to assess the …

Efficacy of double vs. standard empagliflozin dose for METabolic syndromE tReatment (DEMETER—SIRIO 11) study. Rationale and protocol of the study

J Kubica, A Kubica, Z Grąbczewska… - Medical Research …, 2023 - journals.viamedica.pl
Complex metabolic disorders associated with obesity and diabetes pose a serious
therapeutic challenge. The DEMETER-SIRIO 11 study is a phase III, multicenter …

[HTML][HTML] Приверженность терапии после перенесенного инфаркта миокарда и методы ее улучшения

АМ Щинова, АВ Потехина, ЮА Долгушева… - Атеросклероз и …, 2022 - cyberleninka.ru
На настоящий момент приверженность медикаментозной терапии у лиц с сердечно-
сосудистыми заболеваниями, в частности после перенесенного инфаркта миокарда …